Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zoledronate for Bone Loss in Prostate Cancer on ADT
NCT00058188Phase 3Terminated
- Sponsor
- Northwestern University
- Start
- Mar 2003
- Primary completion
- Nov 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of zoledronic acid in osteoporosis, sponsored by Northwestern University. Started Mar 2003; status: terminated.
02
Drugs
zoledronic acid
03
Conditions
osteoporosis
Beyond the preview
Go deeper on NCT00058188.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00058188.